Development of an economic and efficient strategy to detect HBsAg: Application of "gray-zones" in ELISA and combined use of several detection assays

Clinica Chimica Acta

Volumn 412, Issue 23-24, 2011, Pages 2046-2051

  Peng, Jing ^a   Cheng, Liming ^a   Yin, Botao ^a   Guan, Qing ^a   Liu, Yanling ^a   Wu, Shiji ^a   Wang, Bin ^a   Tang, Ning ^a   Zhang, Biyu ^a   Wang, Lian ^a   Yang, Dongliang ^a   Sun, Ziyong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Gray zone diagnosis; Hepatitis b surface antigen (HBsAg); Hepatitis b virus (HBV); Immunoassay

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ANTIGEN DETECTION; ARTICLE; BLOOD ANALYSIS; CHINA; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B VIRUS; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; PRIORITY JOURNAL; PROCESS DEVELOPMENT; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION;

CARRIER STATE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HUMANS; SENSITIVITY AND SPECIFICITY;

HEPATITIS B VIRUS;

EID: 80053629184     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.01.020     Document Type: Article

References (31)

1. World Health Organization Hepatitis B [online] Available from URL [Accessed 2010 Jan 12]. http://www.who.int/csr/disease/hepatitis/whocdscsrlyo20022/en/index1.html.
2. Scheiblauer H, El-Nageh M, Diaz S, et al. Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes. Vox Sang; 98:403-414.
3. Huh H.J., Chae S.L., Cha Y.J. Comparison study with enzyme immunoassay and chemiluminescence immunoassay for hepatitis B virus surface antigen detection. Korean J Lab Med 2007, 27:355-359.
4. Moerman B., Moons V., Sommer H., Schmitt Y., Stetter M. Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays. Clin Lab 2004, 50:159-162.
5. Coleman P.F., Chen Y.C., Mushahwar I.K. Immunoassay detection of hepatitis B surface antigen mutants. J Med Virol 1999, 59:19-24.
6. Chen Y., Wu W., Li L.J., Lou B., Zhang J., Fan J. Comparison of the results for three automated immunoassay systems in determining serum HBV markers. Clin Chim Acta 2006, 372:129-133.
7. Weber B., Dengler T., Berger A., Doerr H.W., Rabenau H. Evaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg) detection: IMMULITE HBsAg and IMMULITE 2000 HBsAg. J Clin Microbiol 2003, 41:135-143.
8. Ismail N., Fish G.E., Smith M.B. Laboratory evaluation of a fully automated chemiluminescence immunoassay for rapid detection of HBsAg, antibodies to HBsAg, and antibodies to hepatitis C virus. J Clin Microbiol 2004, 42:610-617.
9. Miedouge M., Legrand-Abravanel F., Lalanne C., Saune K., Izopet J. Laboratory evaluation of the UniCel DxI 800 analyser (Beckman Coulter) for detecting HBV and HCV serological markers. J Clin Virol 2009, 44:134-137.
10. Muhlbacher A., Weber B., Burgisser P., et al. Multicenter study of a new fully automated HBsAg screening assay with enhanced sensitivity for the detection of HBV mutants. Med Microbiol Immunol 2008, 197:55-64.
11. Weber B., Bayer A., Kirch P., Schluter V., Schlieper D., Melchior W. Improved detection of hepatitis B virus surface antigen by a new rapid automated assay. J Clin Microbiol 1999, 37:2639-2647.
12. Lin Y.H., Wang Y., Loua A., et al. Evaluation of a new hepatitis B virus surface antigen rapid test with improved sensitivity. J Clin Microbiol 2008, 46:3319-3324.
13. Acar A, Kemahli S, Altunay H, et al. The significance of repeat testing in Turkish blood donors screened with HBV, HCV and HIV immunoassays and the importance of S/CO ratios in the interpretation of HCV/HIV screening test results and as a determinant for further confirmatory testing. Transfus Med; 20:152-159.
14. Ziraba AK, Bwogi J, Namale A, Wainaina CW, Mayanja-Kizza H. Sero-prevalence and risk factors for hepatitis B virus infection among health care workers in a tertiary hospital in Uganda. BMC Infect Dis; 10:191.
15. Mina P, Georgiadou SP, Rizos C, Dalekos GN, Rigopoulou EI. Prevalence of occult hepatitis B virus infection in haemodialysis patients from central Greece. World J Gastroenterol; 16:225-231.
16. Elghannam D.M., Aly R.M., Goda E.F., Eltoraby E.E., Farag R.E. Clinical significance of antibody to hepatitis B core antigen in multitransfused hemodialysis patients. Asian J Transfus Sci 2009, 3:14-17.
17. Hu X.B., Yue Q.H., Zhang X.Q., et al. Hepatitis B virus genotypes and evolutionary profiles from blood donors from the northwest region of China. Virol J 2009, 6:199.
18. Akobeng A.K. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr 2007, 96:644-647.
19. Savin C., Sarfati C., Menotti J., et al. Assessment of cryptodiag for diagnosis of cryptosporidiosis and genotyping Cryptosporidium species. J Clin Microbiol 2008, 46:2590-2594.
20. Chen T.S., Li F.Y., Chang F.Y., Lee S.D. Immunoglobulin G antibody against Helicobacter pylori: clinical implications of levels found in serum. Clin Diagn Lab Immunol 2002, 9:1044-1048.
21. Savin C., Huck S., Rolland C., et al. Multicenter evaluation of a commercial PCR-enzyme-linked immunosorbent assay diagnostic kit (Onychodiag) for diagnosis of dermatophytic onychomycosis. J Clin Microbiol 2007, 45:1205-1210.
22. Colloredo G., Bellati G., Leandro G., et al. Quantitative analysis of IgM anti-HBc in chronic hepatitis B patients using a new "gray-zone" for the evaluation of "borderline" values. J Hepatol 1996, 25:644-648.
23. Kamijo K. Study on cutoff value setting for differential diagnosis between Graves' disease and painless thyroiditis using the TRAb (Elecsys TRAb) measurement via the fully automated electrochemiluminescence immunoassay system. Endocr J.
24. Gall D., Nielsen K. Comparison of some methods for determing cutoff values for serological assays: a retrospective study using the fluorescence polarization assay. J Immunoassay Immunochem 2001, 22:85-98.
25. Arif M.A. Importance of confirmatory testing in donated blood. Saudi J Gastroenterol 1998, 4:76-80.
26. Chen D., Kaplan L.A. Performance of a new-generation chemiluminescent assay for hepatitis B surface antigen. Clin Chem 2006, 52:1592-1598.
27. Mair D.C., Brecher M.E., Hom E., Owen H.G., Shea T.C. False-positive hepatitis B surface antigen screening test results in patients receiving granulocyte-colony-stimulating factor. Transfusion 1996, 36:948-951.
28. Allain J.P., Candotti D. Diagnostic algorithm for HBV safe transfusion. Blood Transfus 2009, 7:174-182.
29. Liu Y, Li P, Li C, Zhou J, Wu C, Zhou YH. Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, China. Virol J; 7:193.
30. Fang Z.L., Zhuang H., Wang X.Y., Ge X.M., Harrison T.J. Hepatitis B virus genotypes, phylogeny and occult infection in a region with a high incidence of hepatocellular carcinoma in China. World J Gastroenterol 2004, 10:3264-3268.
31. Wu X., Zhou C., Huang W.J., et al. Sensitivity and specificity of 4 domestic ELISA kits for detection of hepatitis B virus markers. Chin J Epidemiol 2008, 29:915-918.